Eleven health professional schools have been chosen by the National Institutes of Health Pain Consortium to be designated Centers of Excellence in Pain Education. These centers will enhance and improve how health professionals are taught about pain and its treatment.
A new government report suggests that treating drug use as a public health issue could lead to reduced crime rates. The annual report by the White House Office of National Drug Control Policy finds illegal drugs play a central role in criminal acts.
Medical marijuana was a key issue in this week’s Democratic primary race for Oregon Attorney General. A retired state judge who was supported by advocates of the issue defeated a former federal prosecutor who oversaw raids on medical marijuana growers.
Drug wholesale company Cardinal Health said Tuesday it will suspend shipments of controlled substances from a warehouse in Florida for two years, under an agreement with the Drug Enforcement Administration.
The Drug Enforcement Administration (DEA) will create a 12-member investigative unit, based in Cleveland, which will focus on prescription drug cases. The unit will include agents from the DEA, FBI, and local law enforcement agencies.
The Medicaid contractor in Kentucky that announced last week it would stop paying for the opioid addiction medication buprenorphine has reversed its decision, according to The Courier-Journal.
New Jersey Governor Chris Christie’s plan for mandatory treatment for all low-level drug offenders could reduce treatment slots for people who seek treatment voluntarily, but don’t have the money to pay for it, critics say.
New York City Mayor Michael Bloomberg will donate up to $500,000 of his own money to support California’s tobacco tax measure, known as Proposition 29. He challenged supporters to match that amount.
Stolen or fabricated prescription pads are contributing to the surge in prescription drug abuse, experts say. There is a growing call for computer systems that directly link doctors to pharmacies, to avoid this problem.
Use of drugs, particularly cocaine and methamphetamine, is on the decline in the United States, according to U.S. National Drug Control Policy Director R. Gil Kerlikowske. He spoke this week at the Inter-American Drug Abuse Control Commission.